TyVAC 2.0 - The Typhoid Vaccine Acceleration Consortium

The Typhoid Vaccine Acceleration Consortium (TyVAC), a partnership between the Center for Vaccine Development at the University of Maryland School of Medicine, the Oxford Vaccine Group at the University of Oxford, and PATH, an international nonprofit, aims to accelerate the introduction of new typhoid conjugate vaccines (TCVs) as part of an integrated approach to reducing the burden of morbidity and mortality from typhoid in countries eligible for support from Gavi, the Vaccine Alliance (Gavi). Swiss TPH will contribute to analyses that integrate field data into dynamic models of transmission for the purpose of cost-effectiveness analyses.

Involved Regions: Africa, South Asia
Involved Countries: Malawi, Nepal, Bangladesh

Contact

Marina Antillon

Dr. Marina Antillon
Senior Scientific Collaborator

+41612848801
marina.antillonswisstph.ch

Project Facts

Collaborating Institutions